Instil Bio Inc (TIL)
65.62
-2.74
(-4.01%)
USD |
NASDAQ |
Sep 27, 16:00
65.80
+0.18
(+0.27%)
After-Hours: 20:00
Instil Bio Cash from Investing (Quarterly): 11.92M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 11.92M |
| March 31, 2024 | 9.243M |
| December 31, 2023 | 13.95M |
| September 30, 2023 | 2.319M |
| June 30, 2023 | 10.33M |
| March 31, 2023 | 14.53M |
| December 31, 2022 | 32.80M |
| September 30, 2022 | 25.37M |
| June 30, 2022 | -21.50M |
| Date | Value |
|---|---|
| March 31, 2022 | 77.87M |
| December 31, 2021 | 59.96M |
| September 30, 2021 | -516.73M |
| June 30, 2021 | -8.493M |
| March 31, 2021 | -9.129M |
| December 31, 2020 | -45.27M |
| September 30, 2020 | -4.302M |
| June 30, 2020 | -0.275M |
| March 31, 2020 | -1.274M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-516.73M
Minimum
Sep 2021
77.87M
Maximum
Mar 2022
-19.37M
Average
5.781M
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co Inc | -1.069B |
| BioCardia Inc | -0.003M |
| Zevra Therapeutics Inc | -0.129M |
| PetIQ Inc | 0.982M |
| SeaStar Medical Holding Corp | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.61M |
| Free Cash Flow | -52.81M |
| Free Cash Flow Per Share (Quarterly) | -1.632 |
| Free Cash Flow Yield | -12.37% |